Literature DB >> 18828969

Effect of baseline glomerular filtration rate on survival in patients undergoing partial or radical nephrectomy for renal cortical tumors.

Joseph A Pettus1, Thomas L Jang, Robert H Thompson, Ofer Yossepowitch, Meagan Kagiwada, Paul Russo.   

Abstract

OBJECTIVE: To evaluate the effect of baseline renal function and comorbidity index on survival in patients with renal tumors. PATIENTS AND METHODS: We retrieved demographic, clinicopathologic, body mass index (BMI), and comorbidity data (assessed by Charlson-Romano index and hypertension) for 1479 patients who underwent partial or radical nephrectomy between January 4, 1995, and June 9, 2005, for localized renal tumors. We used the abbreviated Modified Diet and Renal Disease equation to estimate glomerular filtration rate (eGFR) using the last preoperative serum creatinine measurement. Body mass index and eGFR time trends were analyzed with linear regression. The effect of BMI, comorbidity, and baseline eGFR on disease-free and overall survival was studied using Cox regression controlling for pathologic stage, nodal status, and metastasis.
RESULTS: Over a 10-year interval, median BMI increased from 27 (interquartile range [IQR], 24-31) to 28 (IQR, 25-31; P=.004), and median baseline eGFR decreased from 70 (IQR, 58-80) to 63 mL/min per 1.73 m(2) (IQR, 57-78; P<.001). Multivariate regression demonstrated an association between year of surgery and baseline eGFR (P<.001) even after adjusting for age, sex, comorbidity, BMI, and tumor size. We repeated the analysis for patients aged 18 to 70 years, and this association persisted (P<.001). Baseline eGFR, BMI, and comorbidity were not associated with disease-free survival after controlling for stage. However, moderately reduced baseline eGFR (45-60 mL/min per 1.73 m(2)) and severely reduced eGFR (<45 mL/min per 1.73 m(2)) were significantly associated with overall survival (hazard ratio, 1.5; P<.003; and hazard ratio, 2.8; P<.001; respectively).
CONCLUSION: Baseline eGFR has declined over the past decade. Nephron-sparing techniques should be considered for patients with severely diminished baseline eGFR.

Entities:  

Mesh:

Year:  2008        PMID: 18828969      PMCID: PMC2636695          DOI: 10.4065/83.10.1101

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  21 in total

1.  Kidney function as a predictor of noncardiovascular mortality.

Authors:  Linda F Fried; Ronit Katz; Mark J Sarnak; Michael G Shlipak; Paulo H M Chaves; Nancy Swords Jenny; Catherine Stehman-Breen; Dan Gillen; Anthony J Bleyer; Calvin Hirsch; David Siscovick; Anne B Newman
Journal:  J Am Soc Nephrol       Date:  2005-10-26       Impact factor: 10.121

2.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

3.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives.

Authors:  P S Romano; L L Roos; J G Jollis
Journal:  J Clin Epidemiol       Date:  1993-10       Impact factor: 6.437

4.  Rising incidence of renal cell cancer in the United States.

Authors:  W H Chow; S S Devesa; J L Warren; J F Fraumeni
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

Review 5.  Increased incidence of serendipitously discovered renal cell carcinoma.

Authors:  M Jayson; H Sanders
Journal:  Urology       Date:  1998-02       Impact factor: 2.649

6.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

7.  Impact of body mass index on survival of patients with surgically treated renal cell carcinoma.

Authors:  S Machele Donat; Elan W Salzhauer; Nandita Mitra; Brent V Yanke; Mark E Snyder; Paul Russo
Journal:  J Urol       Date:  2006-01       Impact factor: 7.450

8.  Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States.

Authors:  Paul Muntner; Jiang He; Lee Hamm; Catherine Loria; Paul K Whelton
Journal:  J Am Soc Nephrol       Date:  2002-03       Impact factor: 10.121

9.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

10.  Predictors of new-onset kidney disease in a community-based population.

Authors:  Caroline S Fox; Martin G Larson; Eric P Leip; Bruce Culleton; Peter W F Wilson; Daniel Levy
Journal:  JAMA       Date:  2004-02-18       Impact factor: 56.272

View more
  19 in total

1.  [Partial nephrectomy. Rationale and limitations of an organ-preserving approach].

Authors:  J Casuscelli; C Gratzke; C G Stief; M Staehler
Journal:  Urologe A       Date:  2012-09       Impact factor: 0.639

2.  Robot-assisted versus laparoscopic partial nephrectomy for localized renal tumors: a meta-analysis.

Authors:  Xiaolong Zhang; Jiajun Yan; Yu Ren; Chong Shen; Xiangrong Ying; Shouhua Pan
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  Canadian Urological Association guideline for followup of patients after treatment of non-metastatic renal cell carcinoma.

Authors:  Wassim Kassouf; Leonardo L Monteiro; Darrel E Drachenberg; Adrian S Fairey; Antonio Finelli; Anil Kapoor; Jean-Baptiste Lattouf; Michael J Leveridge; Nicholas E Power; Frederic Pouliot; Ricardo A Rendon; Robert Sabbagh; Alan I So; Simon Tanguay; Rodney H Breau
Journal:  Can Urol Assoc J       Date:  2018-05-31       Impact factor: 1.862

4.  Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma: A Prospective Cohort Study.

Authors:  Jeremiah J Morrissey; Vincent M Mellnick; Jingqin Luo; Marilyn J Siegel; R Sherburne Figenshau; Sam Bhayani; Evan D Kharasch
Journal:  JAMA Oncol       Date:  2015-05       Impact factor: 31.777

5.  Tumor size is associated with compensatory hypertrophy in the contralateral kidney after radical nephrectomy in patients with renal cell carcinoma.

Authors:  Bong Hee Park; Hyun Hwan Sung; Byong Chang Jeong; Seong Ii Seo; Seong Soo Jeon; Hyun Moo Lee; Han Yong Choi; Hwang Gyun Jeon
Journal:  Int Urol Nephrol       Date:  2016-02-26       Impact factor: 2.370

Review 6.  Partial nephrectomy versus radical nephrectomy for clinical localised renal masses.

Authors:  Frank Kunath; Stefanie Schmidt; Laura-Maria Krabbe; Arkadiusz Miernik; Philipp Dahm; Anne Cleves; Mario Walther; Nils Kroeger
Journal:  Cochrane Database Syst Rev       Date:  2017-05-09

7.  Radical versus partial nephrectomy, chronic kidney disease progression and mortality in US veterans.

Authors:  Elani Streja; Kamyar Kalantar-Zadeh; Miklos Z Molnar; Jaime Landman; Onyebuchi A Arah; Csaba P Kovesdy
Journal:  Nephrol Dial Transplant       Date:  2018-01-01       Impact factor: 5.992

8.  Renal oncocytosis: management and clinical outcomes.

Authors:  Ari Adamy; William T Lowrance; David S Yee; Kian Tai Chong; Melanie Bernstein; Satish K Tickoo; Jonathan A Coleman; Paul Russo
Journal:  J Urol       Date:  2011-01-15       Impact factor: 7.450

9.  Urinary biomarkers for the early diagnosis of kidney cancer.

Authors:  Jeremiah J Morrissey; Amy N London; Jingqin Luo; Evan D Kharasch
Journal:  Mayo Clin Proc       Date:  2010-04-07       Impact factor: 7.616

10.  Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies.

Authors:  William T Lowrance; R Houston Thompson; David S Yee; Matthew Kaag; S Machele Donat; Paul Russo
Journal:  BJU Int       Date:  2009-07-06       Impact factor: 5.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.